What happened✓ From the company's filing
The US Food and Drug Administration inspected Natco Pharma's plant in Kothur, Hyderabad from 12 to 20 November 2026. After the inspection it gave the company seven observations in Form 483. Natco Pharma said the observations are procedural in nature and it is confident of addressing them in time.
How big is this for Natco Pharma?SMALL
7observations
7 observations were listed after the 12 to 20 November inspection.
What changes for Natco PharmaOur view
- −
USFDA listed 7 observations at its Hyderabad plant
Inspection was 12 to 20 November 2026
- ?
It is not yet known if any US approval will be delayed
- +
Natco Pharma said the observations are procedural and it is confident of addressing them in time
Who is affected
- NATCOPHARMDirectly: The inspected Hyderabad plant is owned by Natco Pharma